OBN Appoints CEO
This article was originally published in Scrip
OBN, the membership organisation for the UK's emerging life sciences companies, has appointed John Harris CEO, replacing interim CEO Ross Sommerville. Harris is currently delivering business and export advice to UK trade and industry clients and assisting life science companies on growth strategies. Most recently, Harris was managing partner of Qube Associates and previously he was managing director of IPS Specials/Vertical Pharma Ltd., Key Organics Ltd. and Synerga Ltd.